S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
"Prepare for Five Years of Famine" (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
"Prepare for Five Years of Famine" (Ad)
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
"Prepare for Five Years of Famine" (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
"Prepare for Five Years of Famine" (Ad)
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
"Prepare for Five Years of Famine" (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
"Prepare for Five Years of Famine" (Ad)
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
"Prepare for Five Years of Famine" (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
"Prepare for Five Years of Famine" (Ad)
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
MUST WATCH: Unusual 3-second financial maneuver (Ad)
NYSE:AVTR

Avantor - AVTR Stock Forecast, Price & News

$27.86
-0.48 (-1.69%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$27.67
$28.51
50-Day Range
$27.86
$33.38
52-Week Range
$27.50
$44.37
Volume
5.18 million shs
Average Volume
5.12 million shs
Market Capitalization
$18.78 billion
P/E Ratio
29.96
Dividend Yield
N/A
Price Target
$39.00

Avantor MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.93 Rating Score
Upside/​Downside
40.0% Upside
$39.00 Price Target
Short Interest
Healthy
1.49% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.70
Upright™ Environmental Score
News Sentiment
-0.36mentions of Avantor in the last 14 days
Based on 19 Articles This Week
Insider Trading
Selling Shares
$1.85 M Sold Last Quarter
Proj. Earnings Growth
13.79%
From $1.45 to $1.65 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.29 out of 5 stars

Medical Sector

3rd out of 1,098 stocks

Analytical Instruments Industry

1st out of 31 stocks

AVTR stock logo

About Avantor (NYSE:AVTR) Stock

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Avantor Trading Down 1.7 %

Shares of AVTR traded down $0.48 during trading hours on Tuesday, hitting $27.86. The stock had a trading volume of 5,177,452 shares, compared to its average volume of 5,116,820. The company's fifty day simple moving average is $30.54 and its 200 day simple moving average is $32.31. The company has a debt-to-equity ratio of 1.41, a quick ratio of 1.05 and a current ratio of 1.64. Avantor has a 12-month low of $27.50 and a 12-month high of $44.37. The firm has a market cap of $18.78 billion, a P/E ratio of 29.96, a P/E/G ratio of 0.71 and a beta of 1.30.

Avantor (NYSE:AVTR - Get Rating) last released its quarterly earnings data on Thursday, July 28th. The company reported $0.37 EPS for the quarter, missing the consensus estimate of $0.38 by ($0.01). Avantor had a net margin of 8.27% and a return on equity of 27.14%. The company had revenue of $1.91 billion during the quarter, compared to analysts' expectations of $1.98 billion. During the same period last year, the business earned $0.35 earnings per share. The company's revenue for the quarter was up 2.7% compared to the same quarter last year. Equities research analysts forecast that Avantor will post 1.45 EPS for the current fiscal year.

Wall Street Analyst Weigh In

AVTR has been the topic of a number of analyst reports. Barclays lowered their target price on Avantor to $33.00 in a report on Tuesday. Wells Fargo & Company decreased their price objective on Avantor from $42.00 to $33.00 and set an "overweight" rating on the stock in a report on Monday, April 25th. Morgan Stanley decreased their price objective on Avantor from $40.00 to $37.00 and set an "overweight" rating on the stock in a report on Monday, August 1st. Cowen decreased their price objective on Avantor to $39.00 in a report on Tuesday. Finally, The Goldman Sachs Group decreased their price objective on Avantor from $42.00 to $37.00 and set a "buy" rating on the stock in a report on Thursday, July 14th. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $39.00.

Insider Buying and Selling at Avantor

In other news, EVP Frederic Vanderhaegen sold 39,000 shares of Avantor stock in a transaction dated Monday, May 23rd. The stock was sold at an average price of $31.61, for a total transaction of $1,232,790.00. Following the sale, the executive vice president now directly owns 126,764 shares of the company's stock, valued at $4,007,010.04. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, EVP Gerard Brophy sold 19,603 shares of Avantor stock in a transaction dated Friday, May 20th. The stock was sold at an average price of $31.27, for a total value of $612,985.81. Following the completion of the transaction, the executive vice president now directly owns 96,935 shares in the company, valued at $3,031,157.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Frederic Vanderhaegen sold 39,000 shares of Avantor stock in a transaction dated Monday, May 23rd. The stock was sold at an average price of $31.61, for a total value of $1,232,790.00. Following the completion of the transaction, the executive vice president now owns 126,764 shares of the company's stock, valued at $4,007,010.04. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.

Receive AVTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.

AVTR Stock News Headlines

Avantor (NYSE:AVTR) PT Lowered to $35.00 at Evercore ISI
Avantor (NYSE:AVTR) Given New $33.00 Price Target at Barclays
Avantor (NYSE:AVTR) Given New $33.00 Price Target at Barclays
Raymond James Cuts Avantor (NYSE:AVTR) Price Target to $36.00
Avantor (NYSE:AVTR) Price Target Lowered to $32.00 at Citigroup
Recap: Avantor Q2 Earnings - Benzinga
See More Headlines
Receive AVTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.

AVTR Company Calendar

Last Earnings
7/28/2022
Today
8/10/2022
Next Earnings (Estimated)
10/27/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
13,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$39.00
High Stock Price Forecast
$51.00
Low Stock Price Forecast
$32.00
Forecasted Upside/Downside
+40.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.93
Research Coverage
14 Analysts

Profitability

Net Income
$572.60 million
Pretax Margin
10.45%

Debt

Sales & Book Value

Annual Sales
$7.39 billion
Cash Flow
$2.05 per share
Book Value
$5.24 per share

Miscellaneous

Free Float
663,250,000
Market Cap
$18.78 billion
Optionable
Not Optionable
Beta
1.30














AVTR Stock - Frequently Asked Questions

Should I buy or sell Avantor stock right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last year. There are currently 1 hold rating and 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AVTR shares.
View AVTR analyst ratings
or view top-rated stocks.

What is Avantor's stock price forecast for 2022?

14 equities research analysts have issued twelve-month price objectives for Avantor's shares. Their AVTR share price forecasts range from $32.00 to $51.00. On average, they anticipate the company's stock price to reach $39.00 in the next twelve months. This suggests a possible upside of 40.0% from the stock's current price.
View analysts price targets for AVTR
or view top-rated stocks among Wall Street analysts.

How has Avantor's stock price performed in 2022?

Avantor's stock was trading at $42.14 at the beginning of the year. Since then, AVTR stock has decreased by 33.9% and is now trading at $27.86.
View the best growth stocks for 2022 here
.

Are investors shorting Avantor?

Avantor saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 10,900,000 shares, an increase of 59.1% from the June 15th total of 6,850,000 shares. Based on an average trading volume of 5,270,000 shares, the days-to-cover ratio is presently 2.1 days.
View Avantor's Short Interest
.

When is Avantor's next earnings date?

Avantor is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our AVTR earnings forecast
.

How were Avantor's earnings last quarter?

Avantor, Inc. (NYSE:AVTR) announced its earnings results on Thursday, July, 28th. The company reported $0.37 earnings per share for the quarter, missing analysts' consensus estimates of $0.38 by $0.01. The business had revenue of $1.91 billion for the quarter, compared to the consensus estimate of $1.98 billion. Avantor had a trailing twelve-month return on equity of 27.14% and a net margin of 8.27%. The company's quarterly revenue was up 2.7% on a year-over-year basis. During the same quarter last year, the business posted $0.35 EPS.

What guidance has Avantor issued on next quarter's earnings?

Avantor issued an update on its FY 2022 earnings guidance on Monday, August, 8th. The company provided EPS guidance of $1.43-$1.49 for the period, compared to the consensus estimate of $1.50. The company issued revenue guidance of -.

What other stocks do shareholders of Avantor own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include Honeywell International (HON), Johnson & Johnson (JNJ), NVIDIA (NVDA), Procter & Gamble (PG), Raytheon Technologies (RTX), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Pfizer (PFE) and QUALCOMM (QCOM).

When did Avantor IPO?

(AVTR) raised $3 billion in an initial public offering (IPO) on Friday, May 17th 2019. The company issued 154,000,000 shares at a price of $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies acted as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

What is Avantor's stock symbol?

Avantor trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVTR."

Who are Avantor's major shareholders?

Avantor's stock is owned by a variety of institutional and retail investors. Top institutional investors include Pictet Asset Management SA (1.28%), Parnassus Investments LLC (1.11%), Robeco Schweiz AG (0.86%), Close Asset Management Ltd (0.75%), Pendal Group Ltd (0.54%) and TD Asset Management Inc. (0.40%). Insiders that own company stock include Christi Shaw, Christophe Couturier, David D Petratis, Devashish Ohri, Frederic Vanderhaegen, Gerard Brophy, James Bramwell, Jo Natauri, Justin Miller, Michael Stubblefield, Michael Wondrasch, New Mountain Investments Iii,, Rajiv Gupta and Steven W Eck.
View institutional ownership trends
.

How do I buy shares of Avantor?

Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avantor's stock price today?

One share of AVTR stock can currently be purchased for approximately $27.86.

How much money does Avantor make?

Avantor (NYSE:AVTR) has a market capitalization of $18.78 billion and generates $7.39 billion in revenue each year. The company earns $572.60 million in net income (profit) each year or $0.93 on an earnings per share basis.

How many employees does Avantor have?

Avantor employs 13,500 workers across the globe.

How can I contact Avantor?

Avantor's mailing address is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. The official website for the company is www.avantorsciences.com. The company can be reached via phone at (610) 386-1700 or via email at avantorir@avantorsciences.com.

This page (NYSE:AVTR) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.